SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)
Clinical trial NCT07342621 · RECRUITING
Trial details
- NCT number
- NCT07342621
- Sponsor
- Outcomes'10
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-07
- Primary completion
- 2026-03-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.